111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-3.10%
Revenue decline while CX shows 14.81% growth. Joel Greenblatt would examine competitive position erosion.
No Data
No Data available this quarter, please select a different quarter.
-71.83%
Gross profit decline while CX shows 14.51% growth. Joel Greenblatt would examine competitive position.
-70.93%
Both companies show margin pressure. Martin Whitman would check industry conditions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-93.70%
EBITDA decline while CX shows 0.17% growth. Joel Greenblatt would examine position.
-93.95%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-94.29%
Operating income decline while CX shows 17.78% growth. Joel Greenblatt would examine position.
-94.11%
Operating margin decline while CX shows 2.59% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
137.69%
Tax expense growth above 1.5x CX's 37.78%. Michael Burry would check for concerning trends.
-3.10%
Net income decline while CX shows 47.44% growth. Joel Greenblatt would examine position.
-0.00%
Net margin decline while CX shows 28.42% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-15.19%
Share count reduction while CX shows 1.72% change. Joel Greenblatt would examine strategy.
-16.04%
Diluted share reduction while CX shows 1.72% change. Joel Greenblatt would examine strategy.